News Releases

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

August 13, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

July 28, 2020

Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

July 20, 2020

Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office

July 10, 2020

Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds

July 6, 2020

Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline

July 2, 2020

Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays

June 1, 2020

Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate

May 4, 2020

Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek™ Liquid Biopsy Technology

April 23, 2020

Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics

April 20, 2020

« Previous
1
2
3
4
5
6
7
8
9
10
...21
Next »

Latest News & Events

Dec 8, 2022

Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine

Read More...

Nov 8, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium

Read More...

Oct 31, 2022

Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy

Read More...